{
  "ticker": "JNJ",
  "target_date": "2025-05-16",
  "actual_date": "2025-05-16",
  "collected_at": "2025-12-08T11:46:31.472449",
  "price": {
    "open": 146.39,
    "high": 148.18,
    "low": 145.95,
    "close": 148.0106201171875,
    "volume": 8051200,
    "change_1d_pct": 1.15,
    "change_7d_pct": -3.8,
    "change_30d_pct": -5.31
  },
  "technicals": {
    "rsi_14": 41.91,
    "sma_20": 150.83,
    "sma_50": 153.78,
    "macd": -1.709,
    "macd_signal": -1.234,
    "macd_histogram": -0.475,
    "bb_upper": 156.7,
    "bb_lower": 144.96,
    "price_vs_sma20_pct": -1.87,
    "price_vs_sma50_pct": -3.75,
    "volume_ratio": 1.04
  },
  "fundamentals": {
    "market_cap": 489243508736,
    "pe_ratio": 19.60087,
    "forward_pe": 19.157076,
    "price_to_book": 6.163384,
    "price_to_sales": 5.3092656,
    "profit_margin": 27.26,
    "operating_margin": 30.2,
    "roe": 33.62,
    "roa": 8.26,
    "revenue_growth": 6.8,
    "earnings_growth": 91.0,
    "debt_to_equity": 57.766,
    "current_ratio": 1.074,
    "quick_ratio": 0.711,
    "dividend_yield": 258.0,
    "fifty_two_week_high": 207.81,
    "fifty_two_week_low": 140.68,
    "fifty_day_avg": 193.4922,
    "two_hundred_day_avg": 170.2741,
    "analyst_target": 203.41833,
    "analyst_recommendation": "buy",
    "num_analysts": 24,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - General",
    "pct_from_52w_high": -2.28,
    "pct_from_52w_low": 44.35
  },
  "macro": {
    "spy": {
      "price": 590.81,
      "change_1d_pct": 0.63,
      "change_7d_pct": 5.16
    },
    "vix": {
      "level": 17.24,
      "signal": "NORMAL"
    },
    "treasury_10y": {
      "yield_pct": 4.44
    },
    "dollar_index": {
      "level": 101.09
    },
    "gold": {
      "price": 3182.0
    },
    "regime": "BULL_LOW_VOL"
  },
  "news": [
    {
      "headline": "Jim Cramer Notes That \u201cPeople Are Staying Away From\u201d Johnson & Johnson",
      "source": "Yahoo",
      "datetime": 1747422499,
      "summary": "Cramer noted that investors are skirting Johnson & Johnson (NYSE:JNJ) because of worries regarding Robert Kennedy Jr., as he commented: \u201cOr let\u2019s consider Johnson & Johnson, triple A balance sheet, many drugs in the pipeline, one of the best-run companies in America, if not the world, with perhaps t",
      "url": "https://finnhub.io/api/news?id=73f880eab400bf532e636a91b80d298b851658adfa2325c8406bcd32f0e0baa7"
    },
    {
      "headline": "Pfizer's Turnaround Story Is Stronger Than You Think",
      "source": "SeekingAlpha",
      "datetime": 1747405928,
      "summary": "",
      "url": "https://finnhub.io/api/news?id=f1aa39358b70fbcabefaa095b1113b67f395143069dd178c847bce24ceee8311"
    },
    {
      "headline": "Here's Why Johnson & Johnson (JNJ) is a Strong Value Stock",
      "source": "Yahoo",
      "datetime": 1747402811,
      "summary": "Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.",
      "url": "https://finnhub.io/api/news?id=76ee267ffc144568c9762d1888e841b7ed5e306dbd81bb41a84a1dc97808bb98"
    },
    {
      "headline": "Dow up 120 points on gains in shares of 3M, Nike",
      "source": "MarketWatch",
      "datetime": 1747398240,
      "summary": "Dow up 120 points on gains in shares of 3M, Nike",
      "url": "https://finnhub.io/api/news?id=3d0f6aa9db6e6adc62805817899bbe7e254261394e57c8e1794505445d6ee6b7"
    },
    {
      "headline": "Uk's MHRA Approved Guselkumab (Tremfya) To Treat Crohn'S Disease And Ulcerative Colitis",
      "source": "Finnhub",
      "datetime": 1747397237,
      "summary": "May 16 - UK'S MHRA: * UK'S MHRA: APPROVED GUSELKUMAB TO TREAT CROHN\u2019SDISEASE AND ULCERATIVE COLITIS ...",
      "url": "https://finnhub.io/api/news?id=47425457fb4abfbc5b209431546c486efdeaeac26f231b778e3833fa547d3920"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "13F-HR",
      "date": "2025-05-07",
      "description": "xslForm13F_X02/primary_doc.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000090445425000238/xslForm13F_X02/primary_doc.xml"
    },
    {
      "form": "4",
      "date": "2025-05-05",
      "description": "xslF345X05/wk-form4_1746479407.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000143/xslF345X05/wk-form4_1746479407.xml"
    },
    {
      "form": "8-K",
      "date": "2025-04-30",
      "description": "jnj-20250424.htm",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000141/jnj-20250424.htm"
    },
    {
      "form": "4",
      "date": "2025-04-28",
      "description": "xslF345X05/wk-form4_1745877468.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000138/xslF345X05/wk-form4_1745877468.xml"
    },
    {
      "form": "4",
      "date": "2025-04-28",
      "description": "xslF345X05/wk-form4_1745877247.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000135/xslF345X05/wk-form4_1745877247.xml"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}